A major vaccine scandal, which has created uproar in China this week, might force President Xi Jinping’s government to further open up the pharmaceutical sector to global players. Amid the carnage of fabricated production data and faulty quality control, confidence in the domestic drugs industry has hit rock bottom after Changsheng Biotechnology sold more than 250,000 […]